Welcome to Markets Desk, your midday read on what's moving money and markets.
Disc Medicine priced a six-million-share offering at seventy-five dollars a share Wednesday, raising four hundred fifty million dollars to fund its clinical pipeline. The clinical-stage biotech, trading under the ticker IRON, upsized the deal, signaling strong institutional appetite for its hematology-focused drug development program.
Shifting to infrastructure, Australian data center operator NextDC saw its shares collapse forty percent after slashing its earnings forecast. The company blamed power supply delays at its Melbourne facility, citing local community and stakeholder opposition. It's a sharp reminder that even in the AI-driven data center boom, physical infrastructure bottlenecks can devastate valuations overnight.
And on the exchange wars, the New York Stock Exchange is losing ground in the battle for marquee listings. Anthropic is expected to list on the Nasdaq, following SpaceX, as the Nasdaq continues to dominate high-profile technology debuts. Meanwhile the upstart Texas Stock Exchange is positioning itself as a credible third venue, adding competitive pressure the NYSE can no longer afford to dismiss.
That's the tape. Markets Desk, signing off the floor.
